Universe Pharmaceuticals (UPC) Assets: 2020-2024
- Universe Pharmaceuticals' Assets rose 62.86% to $68.0 million in Q3 2024 from the same period last year, while for Sep 2024 it was $68.0 million, marking a year-over-year increase of 62.86%. This contributed to the annual value of $68.0 million for FY2024, which is 62.86% up from last year.
- Per Universe Pharmaceuticals' latest filing, its Assets stood at $68.0 million for Q3 2024, which was up 37.47% from $49.4 million recorded in Q1 2024.
- Universe Pharmaceuticals' Assets' 5-year high stood at $71.4 million during Q1 2022, with a 5-year trough of $28.8 million in Q3 2020.
- Moreover, its 3-year median value for Assets was $63.7 million (2022), whereas its average is $60.1 million.
- Its Assets has fluctuated over the past 5 years, first spiked by 143.52% in 2021, then fell by 29.92% in 2023.
- Universe Pharmaceuticals' Assets (Quarterly) stood at $28.8 million in 2020, then skyrocketed by 143.52% to $70.1 million in 2021, then declined by 15.12% to $59.5 million in 2022, then declined by 29.92% to $41.7 million in 2023, then soared by 62.86% to $68.0 million in 2024.
- Its Assets was $68.0 million in Q3 2024, compared to $49.4 million in Q1 2024 and $41.7 million in Q3 2023.
